Literature DB >> 3001167

Evidence for ectopic ACTH production years after bilateral adrenalectomy for Cushing's syndrome: in vivo and in vitro studies.

M Boscaro, G Merola, N Sonino, A M Menegus, F Sartori, F Mantero.   

Abstract

Three patients presented with hyperpigmentation and high plasma levels of ACTH 4-5 years after bilateral adrenalectomy for Cushing's "disease". X-rays and ct-scan of the lungs showed a small pulmonary mass in all. ACTH levels (1100-2000 pg/ml) were not suppressible by high doses hydrocortisone. A carcinoid tumor was removed in two cases and a chemodectoma in the third. Evidence for ACTH secretion by these tumors was provided by both decrease of ACTH levels after surgery and/or in vitro studies. Both carcinoid cultures showed a basal ACTH production, which was clearly increased by LVP (10(-7) M) and CRF (10(-7) M). Our findings in vitro studies suggest the presence of specific receptor sites for physiological stimuli (LVP and CRF) in tumor cell membranes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3001167     DOI: 10.1007/bf03348527

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  21 in total

Review 1.  The Cushing syndromes: changing views of diagnosis and treatment.

Authors:  E M Gold
Journal:  Ann Intern Med       Date:  1979-05       Impact factor: 25.391

2.  Cushing's syndrome caused by bronchial adenomas.

Authors:  C A Strott; C A Nugent; F H Tyler
Journal:  Am J Med       Date:  1968-01       Impact factor: 4.965

3.  Experience with selective venous sampling in diagnosis of ACTH-dependent Cushing's syndrome.

Authors:  P L Drury; S Ratter; S Tomlin; J Williams; J E Dacie; L H Rees; G M Besser
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-02

4.  The effects of dopamine, bromocriptine, lergotrile and metoclopramide on prolactin release from continuously perfused columns of isolated rat pituitary cells.

Authors:  T Yeo; M O Thorner; A Jones; P J Lowry; G M Besser
Journal:  Clin Endocrinol (Oxf)       Date:  1979-02       Impact factor: 3.478

5.  Human gamma-lipotropin radioimmunoassay: identification of immunoreactive gamma-lipotropin in human plasma and tissue.

Authors:  R E Wilson; D N Orth; W E Nicholson; C D Mount; X Y Bertagna
Journal:  J Clin Endocrinol Metab       Date:  1981-07       Impact factor: 5.958

Review 6.  Cushing's syndrome: problems in management.

Authors:  D C Aron; J W Findling; P A Fitzgerald; P H Forsham; C B Wilson; J B Tyrrell
Journal:  Endocr Rev       Date:  1982       Impact factor: 19.871

7.  Gamma-melanotrophin-like immunoreactivities in human pituitaries, ACTH-producing pituitary adenomas, and ectopic ACTH-producing tumours: evidence for an abnormality in glycosylation in ectopic ACTH-producing tumours.

Authors:  I Tanaka; Y Nakai; K Nakao; S Oki; J Fukata; H Imura
Journal:  Clin Endocrinol (Oxf)       Date:  1981-10       Impact factor: 3.478

8.  Corticotrophin releasing factor: responses in normal subjects and patients with disorders of the hypothalamus and pituitary.

Authors:  N Lytras; A Grossman; L Perry; S Tomlin; J A Wass; D H Coy; A V Schally; L H Rees; G M Besser
Journal:  Clin Endocrinol (Oxf)       Date:  1984-01       Impact factor: 3.478

9.  The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.

Authors:  G P Chrousos; H M Schulte; E H Oldfield; P W Gold; G B Cutler; D L Loriaux
Journal:  N Engl J Med       Date:  1984-03-08       Impact factor: 91.245

10.  Selective venous sampling for ACTH in Cushing's syndrome: differentiation between Cushing disease and the ectopic ACTH syndrome.

Authors:  J W Findling; D C Aron; J B Tyrrell; J H Shinsako; P A Fitzgerald; D Norman; C B Wilson; P H Forsham
Journal:  Ann Intern Med       Date:  1981-05       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.